Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Elderly Patients (>60 Years) With Acute Myeloblastic Leukemia or Advanced MDS (RAEB-T): An Open Randomized Study to Test the Efficacy of G-CSF-Priming and a Feasibility Trial of Dose-Reduced Allogeneic Transplantation and of Autologous Stem Cell Transplantation

NCT00199147 is registered in ClinicalTrials.gov with Johann Wolfgang Goethe University Hospital as lead sponsor.

NCT NCT00199147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00199147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Elderly Patients (>60 Years) With Acute Myeloblastic Leukemia or Advanced MDS (RAEB-T): An Open Randomized Study to Test the Efficacy of G-CSF-Priming and a Feasibility Trial of Dose-Reduced Allogeneic Transplantation and of Autologous Stem Cell Transplantation
Lead sponsor
Johann Wolfgang Goethe University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2000
Completion date
Not reported
Enrollment
250
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia